Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brukinsa
Marketing
BeiGene bumps AbbVie, J&J from top lymphoma event sponsor spot
BeiGene has inked a three-year deal for the opportunity, bumping AbbVie’s Pharmacyclics and Johnson & Johnson’s Janssen out of the way in the process.
Nick Paul Taylor
Mar 12, 2024 12:03pm
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
BeiGene added 1,400 employees as key cancer drugs expand
Feb 26, 2024 11:03am
Lilly's Jaypirca blazes CLL trail with FDA approval
Dec 4, 2023 4:11am
AbbVie's Imbruvica-Brukinsa patent suit may have merit: expert
Jun 27, 2023 10:48am
Astellas, Eisai and BeiGene—Fierce Pharma Asia
Jun 16, 2023 8:30am